Delivery Order 36C25622D0063-36C25623N1093
- Not listed
- This federal contract award to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, is for medication compounding services provided to the Department of Veterans Affairs Veterans Health Administration (VA-VHA). The $424,949.34 firm fixed-price purchase order was awarded on March 4, 2018, with a completion date of May 31, 2018. Avella, a subsidiary of UnitedHealth Group, has received numerous VA-VHA awards for specialized pharmacy services involving chemotherapy and hazardous...
- This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 21 (VISN 21) to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. The $441,256.72 firm fixed-price delivery order is for the provision of hazardous pharmaceutical compounds to support VA oncology and infusion treatment programs in Las Vegas, Nevada. The contract has no set-aside designation and is not...
- This federal contract award to Optum Pharmacy 801, Inc. (doing business as Avella Specialty Pharmacy) is for chemotherapy compounding services for the Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract has a ceiling value of $97,052.49 and a performance period running through November 16, 2024. Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated, specializes in compounding customized chemotherapy agents, hazardous sterile preparations,...
- This federal contract award is for the delivery of hazardous pharmaceutical compounds to the Department of Veterans Affairs (VA) in Las Vegas, Nevada. The contract, awarded to Optum Pharmacy 801, Inc. (doing business as Avella Specialty Pharmacy), has a ceiling value of $26,259.62 and a performance period ending on September 30, 2024. Avella Specialty Pharmacy is a subsidiary of UnitedHealth Group Incorporated, a large diversified healthcare company that has secured numerous federal contracts...
- This federal contract award is for $37,500.00 in 503A pharmaceutical drug compounding services provided by Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated, to the U.S. Department of Veterans Affairs (VA) under a Firm Fixed Price delivery order. The contract has an ultimate completion date of September 30, 2026. Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, is a 503A certified pharmacy that specializes in advanced pharmaceutical compounding...
- This federal contract award is for chemo compounding services provided by Optum Pharmacy 801, Inc. (doing business as Avella Specialty Pharmacy) to the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 2 (VISN 2). The contract has a ceiling value of $283,000.00 and a period of performance through September 30, 2029. Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated, specializes in compounding customized chemotherapy and other hazardous...
- This federal contract award is for HAZARDOUS PHARMACY COMPOUNDING SERVICES to support the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) oncology and infusion treatment programs. The prime contractor is Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. The contract, valued at $325,000.00, is a Blanket Purchase Agreement (BPA) Call with a Firm Fixed Price pricing type and a performance period through...
- The Department of Veterans Affairs Veterans Health Administration (VA-VHA) awarded a $187,606.76 Firm Fixed Price Purchase Order to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. The contract is for the emergency mixing of chemotherapy compounds to support VA oncology and infusion treatment programs nationwide. Avella will perform the work at its own facilities while partnering with various VA Veterans Integrated Service...
- This is a federal contract award to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated, to provide pharmacy compounding services primarily to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract has a total ceiling value of $1,610,040.41 and a period of performance ending on May 31, 2025. It was awarded on June 1, 2020 as a Delivery Order under a larger Indefinite Delivery Contract (IDC) or Blanket Purchase Agreement (BPA)...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a $976,800.00 firm-fixed price purchase order to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, for the emergency compounding of hazardous chemotherapy drugs. The order was awarded on November 27, 2018 with a performance period through January 31, 2019. Avella, a subsidiary of UnitedHealth Group Incorporated, provides specialized pharmacy services to support VA oncology and infusion...
- 36C25622D0063Indefinite Delivery Contract
- 36C25622D0063-36C25623N1093Delivery Order
This federal contract award is for 503A pharmaceutical drug compounding services provided by Optum Pharmacy 801, Inc. (doing business as Avella Specialty Pharmacy), a subsidiary of UnitedHealth Group Incorporated. The award has a ceiling value of $119,448.79 and is a delivery order contract with a firm fixed price pricing type. The ultimate completion date for the contract is August 24, 2024. The contract was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 16 (VISN 16) to support the VA's oncology and infusion treatment programs nationwide. As a 503A certified pharmacy, Avella Specialty Pharmacy has expertise in aseptic techniques for hazardous drug preparation, enabling it to deliver critical compounded pharmaceutical products to VA medical centers and clinics across the country. This contract is not associated with any set-aside designation. Avella Specialty Pharmacy has several significant Indefinite Delivery Vehicles (IDVs) with the VA-VHA for nationwide chemotherapy compounding and hazardous pharmacy services, allowing the VA to issue task orders as needed.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | ($231k) | 12/12/24 | |
| Not listed | Not listed | $350.0k | 8/16/23 |